Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00981097 · ClinicalTrials.gov registry record
Study of Blood and Tissue Samples From Patients With Aggressive Non-Hodgkin B-Cell Lymphoma or Hodgkin Lymphoma
A clinical trial, sponsored by AIDS Malignancy Consortium.
- Completed
- Registry status
- 52
- Enrollment target
NCT00981097 is a clinical trial that has completed, run by AIDS Malignancy Consortium. The registered enrollment target is 52 participants.
The verdict
NCT00981097 has completed, sponsored by AIDS Malignancy Consortium.
- COMPLETED
- Registry status
- 52 participants
- Enrollment target
Study Summary
RATIONALE: Studying samples of blood and tissue from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer. PURPOSE: This research study is looking at blood and tissue samples from patients with aggressive non-Hodgkin B-cell lymphoma or Hodgkin lymphoma.
Interventions
- OTHER laboratory biomarker analysis
- GENETIC polymerase chain reaction
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 52 participants |
| Start Date | 2009-08 |
| Est. Completion | 2013-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00981097
The ClinicalTrials.gov registry entry for NCT00981097 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 52 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is AIDS Malignancy Consortium, which has 45 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which laboratory biomarker analysis is the first listed.
NCT00981097 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00981097 about?
NCT00981097 is a clinical study titled "Study of Blood and Tissue Samples From Patients With Aggressive Non-Hodgkin B-Cell Lymphoma or Hodgkin Lymphoma". RATIONALE: Studying samples of blood and tissue from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer. PURPOSE: This research study is looking at blood and tissue samples from patients with aggressive non-Ho...
What is the current status of trial NCT00981097?
This trial is currently completed. The enrollment target is 52 participants. The study started on 2009-08. Estimated completion is 2013-06.
What interventions are being tested in trial NCT00981097?
The interventions under investigation include: laboratory biomarker analysis (OTHER), polymerase chain reaction (GENETIC).
Who is sponsoring clinical trial NCT00981097?
This trial is sponsored by AIDS Malignancy Consortium, which has 45 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.